C82.69
Cutaneous follicle center lymphoma, extranodal and solid organ sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Cutaneous follicle center lymphoma (C-FCL) is a type of non-Hodgkin lymphoma that primarily affects the skin. Classified under ICD-10 code C82.69, this rare cancer originates from B-cells within the follicles of lymph nodes but manifests in the skin, making it an extranodal lymphoma. Typically, it presents as painless skin lesions and can resemble other skin conditions, which sometimes complicates diagnosis. While C-FCL is considered indolent or slow-growing compared to other lymphomas, early detection and appropriate management are important for optimal outcomes.
Causes & Symptoms
Clinical Causes: Genetic mutations in B-cell lymphocytes Potential association with immune system dysfunction Although exact causes are unknown, certain genetic and environmental factors may contribute History of other lymphomas or immune-related disorders might increase risk
Key Symptoms: Painless, slowly enlarging skin lesions or nodules Lesions may appear as red, purple, or skin-colored patches or nodules Lesions predominantly found on the trunk, arms, or legs In some cases, multiple skin lesions may be present Rarely, symptoms such as itching or ulceration can occur
Diagnostic & Treatment
Diagnosis Path: Diagnosing cutaneous follicle center lymphoma involves several steps, including:
Treatment Protocols: Treatment options for C-FCL depend on the extent of the disease and patient factors, typically including:
Clinical Advice & FAQs
Billing Guidance
Is C82.69 a billable ICD-10 code?
Yes, C82.69 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.69?
Clinical documentation must specify the nature of Cutaneous follicle center lymphoma, extranodal and solid organ sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference